You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

AMPICILLIN AND SULBACTAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ampicillin And Sulbactam patents expire, and when can generic versions of Ampicillin And Sulbactam launch?

Ampicillin And Sulbactam is a drug marketed by Acs Dobfar, Antibiotice, Astral, Eugia Pharma Speclts, Hikma, Hospira Inc, Hq Speclt Pharma, Istituto Bio Ita Spa, Pharm Assoc, Sandoz, and Steriscience. and is included in twenty-three NDAs.

The generic ingredient in AMPICILLIN AND SULBACTAM is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.

Drug patent expirations by year for AMPICILLIN AND SULBACTAM
Recent Clinical Trials for AMPICILLIN AND SULBACTAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Konya Meram State HospitalPhase 4
Konya Training and Research HospitalPhase 4
Assiut UniversityPhase 4

See all AMPICILLIN AND SULBACTAM clinical trials

Pharmacology for AMPICILLIN AND SULBACTAM

US Patents and Regulatory Information for AMPICILLIN AND SULBACTAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065241-002 Jul 25, 2006 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharm Assoc AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065316-001 Jun 29, 2007 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065310-002 Jul 25, 2006 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.